[PDF] Top 20 Evaluation of cognitive dysfunction in patients with liver cirrhosis
Has 10000 "Evaluation of cognitive dysfunction in patients with liver cirrhosis" found on our website. Below are the top 20 most common "Evaluation of cognitive dysfunction in patients with liver cirrhosis".
Evaluation of cognitive dysfunction in patients with liver cirrhosis
... the patients suffered from gross cognitive ...The patients enroled in their study were of Child Pugh B and C and none of the patients belong to Child Pugh A ...the patients belong to ... See full document
8
THE EFFECT OF PROPRANOLOL IN MALAY PATIENTS WITH LIVER CIRRHOSIS A PHARMACODYNAMIC EVALUATION
... No correlation was seen between HR and V max , thus it could be concluded that HR and cardiac output are not reliable parameters in assessing portal system haemodynamics. It is reasonable to conclude further that ... See full document
9
Original Article Nutrition evaluation and metabolic profiling analysis of liver cirrhosis patients: a cross-sectional study
... of cirrhosis patients is often ...of liver cir- rhosis patients, the current study examined the mutual correlation of these ...120 liver cirrhosis patients and 20 ... See full document
9
Original Article Peripheral sH2a in diagnosis and evaluation of fibrosis condition in liver cirrhosis
... that liver cirrhosis patients present- ed lower sH2a content, which was further sup- pressed with disease ...population, liver cirrhosis patients had lower serum sH2a con- tents ... See full document
6
Negative impact of low body mass index on liver cirrhosis patients with hepatocellular carcinoma
... in liver cirrhosis patients with HCC, in light of the fact that ascetic status could be overestimated in the calculation of ...the evaluation of nutri- tional status, despite its ... See full document
6
Original Article A hemodynamic analysis of renal dysfunction in 79 patients with liver cirrhosis
... in patients with cirrhosis, shunts may occur from the portal vein to the inferior vena cava, such as spontaneous spleno-gastric- renal ...79 patients were studied, with 31 patients in the ... See full document
6
Sleep disturbances in patients with liver cirrhosis: prevalence, impact, and management challenges
... in liver cirrhosis and associated with impaired quality of ...in cirrhosis are complex and may include disturbed metabolism of melatonin and glucose, alterations in thermoregulation, and altered ... See full document
7
Original Article Influence of blood concentration monitoring of isoniazid on liver damage in patients with pulmonary tuberculosis complicated with liver dysfunction
... alone, patients with pulmonary tuberculosis compli- cated with liver dysfunction (PTCLD) have poor pharmacokinetics in the ...with cirrhosis. They found that patients showed higher ... See full document
8
Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine
... underlying liver disease that are associated with an overall poor prognosis without ...all patients have pre-existing chronic liver disease and ...Many patients with HCC do not demonstrate the ... See full document
10
A Study Of Acute Renal Faılure In Patıents Wıth Cırrhosıs Of Liver For Evaluatıon Of Causes,Treatment And Prognosıs: A Prospecto Retrospectıve Study
... cirrhotic patients with renal dysfunction and reported acute tubular necrosis in 8 patients, prerenal ARF in 2 and HRS in ...40 patients with terminal cirrhosis out of which 26 ... See full document
15
Cirrhotic cardiomyopathy among patients with liver cirrhosis
... cirrhotic patients undergoing liver trans- plantation showed signs of cardiac dysfunction [10,28- ...on patients who have had the diagnostic testing and the rates of ab- normalities to be ... See full document
5
Study of Myocardial Dysfunction in Patients with Cirrhosis of Liver
... All patients admitted to General Medicine Department of ...with cirrhosis of liver were included in the study and evaluated clinically with special emphasis on cardiovascular abnormalities in ECG and ... See full document
7
Evaluation of autonomic dysfunction in patients with hepatic cirrhosis.
... of patients with advanced cirrhosis, consisting of elevated cardiac rate and output and reduced peripheral vascular resistance, so that arterial pressure is tendentially or frankly ... See full document
83
Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis
... of liver diseases other than NAFLD, including viral hepatitis (detected with positive serum hepati- tis B surface antigen or hepatitis C viral RNA), Wilson’s disease, hemo- chromatosis, α 1 -antitrypsin ... See full document
9
25-Hydroxy Vitamin D: Novel Biomarker for the Diagnosis of Hepatocellular Carcinoma
... assessment, liver biochemical profile, viral markers, conventional ultrasound (US) and abdominal triphasic CT scan Results: Serum 25(OH)D concentration was significantly lower in HCC patients (3ng/ml) than ... See full document
7
Study on serum homocysteine level as a prognostic marker for alcoholic liver cirrhosis and viral cirrhosis patients.
... fatty liver disease (NAFLD) and non alcoholic steatohepatitis (NASH) ...and liver cirrhosis patients ...induce liver diseases also, by promoting hepatic ... See full document
83
Title: ANTIDIABETIC AND ANTIOXIDANT ACTIVITY OF AQUEOUS ROOT EXTRACT OF CHLOROPHYTUM BORIVILIUANUM (SAFED MUSLI) Author: Hemlata Rathore, Bhushan Hatwar & Shishupal Bodhankar Keyword: Chlorophytum boriviliuanum, Antidiabetic & AntioxidantPage No: 37-43DOI: 10.30876/JOHR.8.3.2019.37-43Abstract: Objective: To investigate the antidiabetic effect of aqueous extract of Chlorophytum borivilianum (safed musli) root. Methods: The collected roots were washed; shade dried and was pulverized with a me chanical pulverizer for the size reduction. It was then passed through mesh of size # 60 and the fine powder was collected and was used for the experiment for powder microscopy and preparation of extract. The root powder (1000 g) was subjected to cold maceration in 2 L of sterile distilled water for 48 hours at room temperature, filtered into a clean round bottom flask. The a- Glucosidase inhibitory activity was conducted where 100µl of a sample of different concentrations was incubated with 50µl a-glucosidase (1.0 U/ml) (from Saccharomyces cerevisiae) in phosphate buffer (0.1 M, pH 6.8) for 10 min at 37°C. The reaction was initiated by addition of 50 µl of substrate: 5 mM, p-nitrophenyl-a-D glucopyranoside in a 0.1 M phosphate buffer at pH 6.8. P-nitrophenol’s release kinetics. The a -Amylase Inhibition where 250µL of the extract (5mg/mL) was preincubated with 250µL of -amylase solution for 10min at 25°C in one set of tubes. In another set of tubes -amylase was preincubated with 250µL of phosphate buffer (pH 6.9). 250µL of starch solution at increasing concentrations (0.30–5.0mg/mL) was added to both sets of reaction mixtures to start the reaction. The mixture was then incubated for 10min at 25°C and then boiled for 5min after the addition of 500µL of DNS to stop the reaction. Results: In this study acarbose was also used as a standard drug for a-glucosidase inhibitor. Acarbose at a concentration of (100-1000 µg/ml) showed a-glucosidase inhibitory activity from 30. 31±0.1084to 84.05±0.2075% with an IC value 411.436567µg dry extract, & acarbose was also used as a standard drug for a amylase inhibitor. Acarbose at a concentration of (100-1000 µg/ml) showed a-glucosidase inhibitory activity from 23.33±0.1415 to 62.05±0.2725% with an IC value 236.774194µg dry extract. Conclusions: As a result, we found that the extract of C. boriviliamum have free radical scavenging activity and inhibitory activity against a-amylase and a-glucosidase and this therapeutic potentiality could be exploited in the management of post prandial hyperglycemia in the treatment of type 2 diabetes mellitus. Download PDF
... Blood enters a lobule from branches of the hepatic artery and portal vein. Arterial blood oxygenates the hepatic cells, whereas blood from the portal system passes through the liver for inspection. Sinusoids in ... See full document
5
Decreased PCSK9 expression in human hepatocellular carcinoma
... the liver, and plays an important role in cholesterol metabolism by regulating LDL receptor ...stimulate liver regen- eration ...against liver metastases, with increased apoptosis of metastatic cells ... See full document
10
AN EVALUATION OF HUMAN SERUM ALBUMIN IN THE TREATMENT OF CIRRHOSIS OF THE LIVER
... Although the protein loss in ascitic fluid was not markedly changed in quantity at any one paracentesis, it is apparent that the period between paracenteses was prolonged by the low sodi[r] ... See full document
13
Magnetic resonance studies in patients with chronic liver disease and following hepatic transplantation
... in patients with chronic ductopenic rejection was significantly increased, compared to that of both healthy volunteers and patients with good graft function, although the Pi SHR and PDE SHR remained ...of ... See full document
285
Related subjects